Healthy Lifestyle Intervention for Emotional Distress During Pregnancy
(A-RCT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program called COPE-P, a cognitive-behavioral therapy program designed to help pregnant minority women experiencing emotional stress. Over six sessions, participants learn skills to better manage stress during pregnancy. The trial compares the effectiveness of this program with standard prenatal education. Women who are early in their pregnancy, identify as Black or Hispanic, and feel emotionally distressed may be suitable candidates for the trial. As an unphased trial, it provides a unique opportunity to contribute to important research that could enhance stress management for pregnant women.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are receiving treatment for a psychiatric diagnosis, you would not be eligible to participate.
What prior data suggests that this intervention is safe for pregnant women?
Research has shown that the COPE-P program is generally safe for pregnant women. This program employs cognitive-behavioral therapy (CBT), a well-established method for enhancing mental health. Studies have found that COPE-P reduces depression, anxiety, and stress in pregnant women experiencing emotional distress. These studies have not reported any serious side effects, indicating that the treatment is well-tolerated.
The COPE-P program is also applied in other contexts, such as with mothers of premature babies, and has demonstrated positive results without major safety concerns. Although specific details on negative effects might not be available, the treatment is grounded in strong research and practice. This suggests that COPE-P is safe for participants in clinical trials.12345Why are researchers excited about this trial?
Researchers are excited about the COPE-P intervention because it offers a fresh approach to tackling emotional distress during pregnancy through cognitive-behavioral therapy (CBT), which is not typically emphasized in standard prenatal care. Unlike traditional methods that primarily focus on physical health through educational materials, COPE-P incorporates skills-building sessions that aim to equip expectant mothers with practical tools to manage stress and emotions. This innovative use of CBT, led by trained healthcare providers, is anticipated to not only enhance mental well-being but also potentially improve outcomes for both mothers and their babies.
What evidence suggests that the COPE-P intervention is effective for emotional distress during pregnancy?
Research has shown that the COPE-P program, available to participants in this trial, can alleviate depression, anxiety, and stress in pregnant women experiencing emotional distress. This program imparts skills to enhance both mental and physical health. Studies involving pregnant minority women have found that COPE-P can lead to healthier births by reducing the risk of high blood pressure problems and early delivery. Additionally, the program promotes healthier habits during pregnancy. Overall, evidence suggests that COPE-P is a promising method for managing emotional distress in this group.12346
Who Is on the Research Team?
Bernadette Melnyk, PhD
Principal Investigator
Ohio State University
Are You a Good Fit for This Trial?
This trial is for Black or Hispanic pregnant women aged 18-40, under 19 weeks into an uncomplicated pregnancy. They must speak English and not have chronic conditions like hypertension or diabetes, psychiatric treatments, or obstetrical complications.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a cognitive behavioral skills building intervention over 6 sessions spaced over 18 weeks
Follow-up
Participants are monitored for changes in self-reported healthy lifestyle beliefs, anxiety, depressive symptoms, and stress from baseline to 6 months postpartum
Postpartum Evaluation
Evaluation of birth outcomes and maternal health at 6-8 weeks postpartum
What Are the Treatments Tested in This Trial?
Interventions
- COPE-P
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
New York University
Collaborator
Jacobi Medical Center
Collaborator
Boston College
Collaborator
University of Arizona
Collaborator
Drexel University
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
University of South Florida
Collaborator